Keywords Clear filters View More 4 results for @keyword Filters More search results loaded Guide for consumers - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard 2024 | Fact sheet The standard contains eight quality statements that describe the health care you should receive to support the correct use of psychotropic medicines. This fact sheet explains each quality statement and what it means for you. On the Radar Issue 708 2025 | Newsletter This issue includes items on suicide prevention, innovation, patient experience, brain injury, primary care, virtual care, sepsis, delirium, and more. Along with the latest from Australian Health Review, Health Affairs, BMJ Quality & Safety, International Journal for Quality in Health Care and the UK’s NICE and the USA’s... Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (2024) 2024 | Standard The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard contains eight quality statements and seven indicators to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment and uphold their rights, dignity, health and quality of life. Information for clinicians - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard 2024 | Fact sheet This resource lists the eight quality statements in the clinical care standard that aim to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment.